<DOC>
	<DOCNO>NCT01356589</DOCNO>
	<brief_summary>This retrospective observational study assess incidence hemoglobin cycle chronic kidney disease ( stage 3 , 4 , 5 ) patient renal anemia treat Mircera ( methoxy polyethylene glycol-epoetin beta ) . Data collect patient 9-month treatment period .</brief_summary>
	<brief_title>A Study MIRCERA Intrapetient Variability Hemoglobin Levels Patients With Chronic Renal Anemia ( RIVAL )</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Chronic kidney disease predialysis ( stage 3 4 ) dialysis Renal anemia treat Mircera accord label least 9 month date sign informed consent Participation interventional clinical trial within retrospective observation period Contraindications Mircera administration per label judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>